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We examined the possibility that cardiomyocytes could be genetically 
marked or modified before being grafted to the heart under conditions 
applicable to the clinical setting. We used a replication-defective r combi- 
nant adenovirus carrying the lB-galactosidase reporter gene, and delivered 
it to cultured murine fetal cardiac myocytes. Virtually all fetal cardiomyo- 
cytes in a primary culture expressed lB-galactosidase 24 hours after 
recombinant adenovirus infection. These cells were transplanted to the  
hearts of syngenic adult recipient mice. Expression of the/3-galactosidase 
gene in the grafted cells was demonstrated by staining with 5-bromo-4- 
chloro-3-indoyl-lB-D-galactosidase, resulting in a blue color at the histo- 
chemical level and an electron-dense deposit on transmission electron 
microscopic analysis. Gene expression was recognized from 7 days to 12 
weeks after transplantation. Implanted cardiomyocytes aligned themselves 
along the layers of the host myocardium. Formation of gap junctions was 
demonstrated by transmission electron microscopy. Neither inflammation 
nor fibrous scar tissue was detectable by histologic analysis. This study 
demonstrates that ex vivo gene transfer to the heart by means of the 
adenoviral vector is possible. (J Thorac Cardiovasc Surg 1997;113:10-8) 
C ardiac cell transplantation is one potential treat- 
ment for acute or chronic heart failure with a 
significant loss of myocardium. Until recently, how- 
ever, cardiac cell transplantation has received min- 
imal attention. Prerequisites for cellular t~:ansplan- 
tation to the heart to be successful include the 
following: (1) the formation of a new functional 
syncytium between grafted and host cardiomyocytes, 
(2) a number of grafted cells large enough to 
improve cardiac function, and (3) long-term graft 
survival. Cellular transplantation to the heart has 
been investigated primarily with transformed cell 
lines 1-4 and satellite cells 5' 6 as the donor cells. These 
cells usually survived for 2 months after implanta- 
From the Departments of Surgery IIIa and Anatomy, b Nara 
Medical College, Nara, and the Laboratory of Molecular 
Genetics, c Institute of Medical Science, University of Tokyo, 
Tokyo, Japan. 
Supported in part by a grant from the Ministry of Health and 
Welfare, Tokyo, Japan. 
Received for publication Nov. 17, 1995; revisions requested Feb. 
22, 1996; revisions received April 17, 1996; accepted for 
publication April 25, 1996. 
Address for reprints: Satoshi Gojo,MD, Department ofSurgery 
III, Nara Medical College, 840 Shijo-cho, Kashihara, Nara 
634, Japan. 
Copyright © 1997 by Mosby-Year Book, Inc. 
0022-5223/97 $5.00 + 0 12/1/74601 
10 
tion but did not form intercalated disks within the host 
myocardium. Recently, studies with transgenic mice 
carrying a /3-galactosidase (/3-gal) transgene showed 
that the intracardiac grafting of fetal cardiomyocytes 
resulted in the formation of intercalated disks between 
the grafted fetal cardiomyocytes and the recipient 
myocardium. 7 The transfer of a therapeutic gene in 
the cells to be grafted may possibly raise cardiac cell 
transplantation from an experimental study to a clini- 
cal treatment. At present, however, it is unknown 
whether ex vivo genetically engineered cardiomyocytes 
can be grafted. To examine this issue, we performed 
cell transplantation f the fetal myocardial cells with a 
recombinant adenovirus expressing the/3-gal reporter 
gene as the gene transfer vector. 
Materials and methods 
Mice. All animals received humane care in compliance 
with the "Principles of Laboratory Animal Care" formulated 
by the National Society for Medical Research and the 
"Guide for the Care and Use of Laboratory Animals" 
prepared by the Institute of Laboratory Animal Resources 
and published by the National Institutes of Health (NIH 
Publication No. 86-23, revised 1985). Adult BALB/c mice 
were purchased from Clea Japan, Inc., Tokyo, Japan. All 
animals were bred and maintained in a laminar-flow rack in 
our animal facility. All mice were 12 to 16 weeks old when 
used in experiments. Mice w re mated overnight, and the 
fertilized female mice were selected the next morning (0.5 
embryonic day) on the basis of the presence of a vaginal 
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plug. Fetuses were obtained from timed pregnancies atday 
16.5 of gestation. 
Adenoviral vector construction. The replication-defi- 
cient recombinant adenovirus (AdexlCALacZ) was con- 
structed by in vivo homologous recombination i  293 cells 
between the expression cosmid cassette and the parental 
virus genome. The recombinant adenovirus was generated 
through a modification of the method of Salto and 
coworkers. 8 Briefly, an expression cosmid cassette was 
constructed by inserting the expression unit, 9 composed of 
the cytomegalovirus enhancer plus chicken /3-actin pro- 
moter, a complementary deoxyribonucleic a id (DNA) 
coding sequence of a/3-gal gene, and the rabbit/3-globin 
polyadenylate signal sequence, into the SwäI site of 
pAdexlw, which is a 42 kb cosmid containing a 31 kb 
adenovirus type 5 genome lacking EIA, E1B, and E-3 
genes (Fig. 1). The expression cosmid cassette and ade- 
novirus DNA-terminal protein complex were cotrans- 
fected into 293 cells (ATCC; CRL1573) by calcium phos- 
phate precipitation. Incorporation of the expression 
cassette into the isolated recombinant virus was confirmed 
by digestion with appropriate restriction enzymes. The 
recombinant viruses were subsequently propagated with 
293 cells, and viral solution was stored at -80  ° C. 
Generation of high-titer viral stocks. To prepare the 
adenovirus tock, a Bioruptor 200 (Cosmo Bio Co., To- 
kyo, Japan) was used for disrupting the infected 293 cells. 
Lysates of 293 cells infected with the AdexlCALacZ virus 
were used to reinfect 293 cells two more times. The third 
lysates were centrifuged through cesium chloride gradi- 
ents. a° Purified virus was stored at -80  ° C until use. The 
titers of the viral stocks were measured by an end-point 
cytopathic effect assay, a~ A 50 /xl portion of Dulbecco's 
modified essential medium (D-MEM) supplemented with 
5% fetal calf serum (FCS) was dispensed into each well of 
a 96-well tissue-culture plate. Eight rows of threefold 
serial dilutions of the virus, starting from a 10 -4 dilution, 
were then prepared. Next, 3 × 10 » 293 cells in 50 /xl 
D-MEM containing 5% FCS were added to each well. 
The plate was incubated at 37 ° C in 5% carbon dioxide in 
air, and 50/xl D-MEM supplemented 10% FCS was added 
to each weil every 3 days. Twelve days later, the cytopathic 
effect was determined by light microscopy and the 50% 
tissue-culture infectious dose (TCIDso) was calculated. 
One TCIDso/ml corresponds to approximately 1 plaque- 
forming unit (pfu)/ml. In this experiment, he titer of 
recombinant adenovirus was 2 × 109 TCIDso/ml. 
Primary culture of murine fetal cardiomyocytes. 
Mouse heart ventricles were removed from BALB/c fe- 
tuses at day 16.5 of gestational age, minced, and resus- 
pended in phosphate-buffered saline solution (PBS) con- 
taining calcium (1.7 mmol/L) and magnesium (1.5 mmol/ 
L). The resultant fragments were digested with 0.06% 
trypsin for 5 minutes at 37 ° C in a carbon dioxide incuba- 
tor with a magnetic stir bar operating at low speed. The 
supernatant was replaced by 0.06% trypsin in PBS without 
the divalent cations, and the digestion was carried out 
again under the same conditions. This treatment was 
repeated four more times. The supernatants from the 
second to the fifth incubations were transferred to test 
tubes containing cold D-MEM supplemented with 10% 
FCS. After centrifugation at 350g for 3 minutes, the 
A 
D 
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Fig. 1. Structure of AdexlCALacZ vector. In place of 
E1A and E1B, an expression unit composed of chicken 
/3-actin promoter with cytomegalovirus enhancer (CAG), 
B-gal gene (LacZ) complementary DNA, and a polyade- 
nylate signal (pA) was introduced to generate 
AdexlCALacZ expression vector. 
supernatant was discarded and the cells were resuspended 
in D-MEM containing 10% FCS. The suspension was 
seeded into glass petri dishes and incubated for 1 hour at 
37 ° C in 5% carbon dioxide/95% air to exclude nonmyo- 
cytes. 12 The supernatant and nonadherent cells were then 
collected and filtered through a Swinnex filter (Millipore 
Corporation, Bedford, Mass.) with lens paper to remove 
large clumps of cells. The filtered cells were seeded into 35 
mm collagen-coated plastic culture dishes at 2 × 10 » 
cells/dish. The dishes were incubated in D-MEM supple- 
mented with 10% FCS at 37 ° (2 in a humidified atmo- 
sphere of 5% carbon dioxide/95% air. Almost all the 
myocytes attached to the culture dish and beat spontane- 
ously after 1 day (Fig. 2, A). 
Infection of the adenoviral vector into cardiomyocytes. 
On day 1 after seeding the murine fetal cardiac ells, the 
cultures were incubated with 100/xl AdexlCALacZ virus 
stock at various concentrations (multiplicity of infection 
[MOI] of 1000, 100, 10, 1, or 0.1) and D-MEM supple- 
mented with 10% FCS without the adenoviral vector for 
60 minutes at 37 ° C. The cells were washed three times to 
remove any virus remaining on the cell surface. The 
infected cells were incubated in D-MEM supplemented 
with 10% FCS at 37 ° C in a carbon dioxide incubator for 
1 day. These cells were used for 5-bromo-4-chloro-3- 
indoyl-/3-D-galactoside (X-gal) staining and cell transplan- 
tation to the heart. The creatine kinase (CK) values of the 
supernatant were measured 1 hour after the adenoviral 
infection, and the numbers of living and dead cells were 
also counted 24 hours after tlae infection to evaluate 
damage to the cardiac ells at various concentration f the 
adenovirus (n = 5 each group). We used 6 cm culture 
dishes seeded at 1 × 106 cells per dish to assess CK value 
and the numbers of alive and dead cells, because we could 
not detect significant increase of CK value at 2 × 10 » cells. 
X-gal staining of cultnred cardiomyocytes. One day 
after the adenoviral infection, the medium of the infected 
cultures was discarded and 1 ml 0.05% glutaraldehyde was 
added to fix the cells. After 10 minutes of fixation, the 
myocytes were rinsed three times in PBS. They were then 
overlaid with 1 mg/tal X-gal with 15 mmol/L potassium 
ferricyanide, 15 mmol/L potassium ferrocyanide, and 2 
12 
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Fig. 2. X-gal staining of cultured routine fetal cardiac cells. A, Microscopic photograph of culture 1 day 
after cells had been plated. Approximately 90% to 95% of cultured cells in each field beat spontaneously. 
Beating rate in these myocytes was not uniform. Clusters, however, did beat syuchronously. X-gal staining 
was performed 1day after adenovirus infection. B, All cells had assays positive for/3-gal showing blue color, 
at 10 MOI. Bars indicate 100/~m. 
mmol/L magnesium chloride in PBS (X-gal solution) and 
incubated for 1 hour at 37 ° C. 
Measurement ofCK. CK activity in the culture medium 
was measured 1 hour after the adenoviral infection, a3 
Briefly, after mixing of the culture medium with the assay 
solution, the assay reaction was started by the addition of 
creatine phosphate. The production of reduced nicotin- 
amide adenine dinucleotide phosphate was measured at 
340 nm. 
Cell transplantation into syngenie adult mice. Cul- 
tured cells were prepared for transplantation by 
trypsinization, resuspension i D-MEM containing 10% 
FCS, and washing three times with serum-free D-MEM to 
avoid contamination by AdexlCALacZ. The fourth resus- 
pension was used as the implanted cell population. The 
final cell density for implantation was 5 x l07 to 1 x 108 
cells/ml, and the suspension was kept on ice until trans- 
plantation. Cell viability in suspension, determined by 
0.05% erythrosine dye exclusion, was 90% to 95%. After 
the initiation of general anesthesia in the recipient mice 
by an intraperitonial injection of 0.05 mg/g weight pento- 
barbiturate, a transverse incision under the arch of a rib 
was made. The xiphoid process was inverted to the head, 
and the liver was pushed inferiorly so that the heart 
became visible through the diaphragm. Immediately be- 
fore implantation, the cell suspension was drawn up into a 
10/~1 Hamilton syringe with a 31-gauge needle. A 10/~1 
portion of the cell suspension was injected through the 
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diaphragm directly into the ventricular myocardium of each 
syngenic adult recipient mouse (fetal cardiomyocytes, n = 
60). The final supernatant used for rinsing the donor cells 
was plated on the top of NIH 3T3 cells, and the cells were 
stained with the X-gal solution 24 hours later. Moreover, 10 
/xl of the third supernatant or a plasmid DNA (1 /xg//xl) 
containing the expression unit (including/3-gal gene) of the 
adenoviral vector was injected into the ventricular myocar- 
dium of each syngenic adult mouse (n = 10 each). The only 
complication of this procedure was pneumothorax in one 
animal in an early experiment. 
Histologic examinations of the heart. Some of the ani- 
mals grafted with fetal cardiomyocytes were killed each week 
(five after 1 week and three each, weeks 2 to 12) after 
electrocardiograms were recorded for 1 hour to determine 
whether the cellular grafting caused any injuries to the host 
hearts. The hearts were dissected and fixed in 4% parafor- 
maldehyde for I hour. The hearts were sliced (400/xm thick) 
with a Vibratome slicer (Technical Product International, 
Ltd., St. Louis, Mo.), Oxford Co.), refixed in the same 
solution for 2 hours, and washed in PBS followed by over- 
night incubation in the X-gal solution. Sliced hearts with a 
positive assay for /3-gal activity were used for histologic 
studies. Sections in paraffin (4/xm) were stained with hema- 
toxylin-eosin (HE). Cryostat sections (6/xm) were mounted 
on poly-L-lysine-coated glass slides for immunohistologic 
staining. The sections were incubated for 30 minutes with 
PBS containing 1% bovine serum albumin, followed by 
overnight incubation at 4 ° C with phycoerythrin-conjugated 
14 anti-Thy-l.2 (T-lymphocyte marker) and fluorescein iso- 
thiocyanate-conjugated nti-Mac-1 (macrophage marker) 15 
monoclonal ntibodies. Moreover, the sections with a posi- 
tive assay for/3-gal activity were refixed with 2.5% glutalal- 
dehyde in 0.1 mol/L phosphate, pH 7.2, for 3 hours at 4 ° C, 
and postfixed with 1% osminm tetroxide for 1 hour at 4 ° C. 16 
They were dehydrated in ethanol and embedded in Epon 
spurr resin (Polysciences, Inc., Warrington, Pa.). Ultrathin 
sections (0.1 /xm thick) were cut with an ultramicrotome 
(Reichert Ultracut E; Reichert-Jung Optische Werke AG, 
Wien, Austria), stained in 4% uranyl acetate for 20 minutes 
and observed under a JEM 1200EX electron microscope 
(JEOL Ltd, Tokyo, Japan). The hearts, which were injected 
with the final supernatant or the plasmid DNA used for 
rinsing the donor cells, were stained with X-gal 7 days after 
the injection (n = 10 each). 
Results 
Adenovirus mediated gene transfer to cultured 
cardiomyocytes. Damage to the cultured cardiomy- 
ocytes by the infection procedure was examined by 
measuring CK release into the culture medium and 
by counting the numbers of living and dead cells. 
The median CK values in five samples were 6.9 IU/L 
(6.3 to 6.9 IU/L) in 1000 MOI, 2.3 IU/L (1.8 to 2.8 
IU/L) in 100 MOI, 0.5 IU/L (0.5 to 1.2 IU/L) in 10 
MOI, 1.2 IU/L (0.5 to 1.2 IU/L) in 1 MOI, 0.5 IU/L 
(0.5 to 1.2 IU/L) in 0.1 MOI, and 0.5 IU/L (0.2 to 0.5 
IU/L) in the control group. The median numbers of 
living cells in five samples were 3.1 × 10 » (2.7 to 
3.7 X 105) in 1000 MOI, 7.2 x 105 (6.2 to 8.2 x 10 s) 
in 100 MOI, 6.9 × 10 » (6.4 to 8.0 × 105) in 10 MOI, 
6.9 X l0 s (6.3 to 7.6 × 105) in 1 MOI, 7.4 × 10 s (6.9 
to 8.0 × l0 s) in 0.1 MOI, and 7.4 x l0 s (6.2 to 8.0 x 
105) in the control group. The median numbers of 
dead cells in five samples were 37 × 104 (30 to 42 × 
104) in 1000 MOI, 5 × 104 (2 to 6 × 104) in 100 
MOI, 2 × 104 (1 to 4 × 104) in 10 MOI, 2 × 104 (2 
to 3 X 104) in 1 MOI, 2 × 10 4 (1 to 3 × 104) in 0.1 
MOI, and 2 × 104 (1 to 4 × 104) in the control 
group. To find a concentration with significant cyto- 
toxity of the recombinant adenovirus, these results 
were tested by means of a Wilcoxon rank-sum test. 
In terms of CK value, 1000 and 100 MOI had a 
significant difference from the control group (p < 
0.05). In terms of the numbers of living and dead 
cells, 1000 MOI had a significant difference from the 
control group (p < 0.05). These results indicated 
that the adenoviral infection at 10 MOI was safe 
with respect to cytotoxic effects. Almost all cells 
contracted throughout the culture period, even dur- 
ing the infectious period. One week after gene 
transfer, these cells formed confluent sheets and 
beat synchronously. Adenoviral infections appar- 
ently did not inhibit the electrical coupling that is 
essential for synchronous beating. 
Gene transfer was assessed initially by X-gal 
staining. Virtually all cells in culture dishes showed 
blue color at more than 10 MOI (Fig. 2, B). This 
means that/3-gal was expressed in these cells. About 
half of the cultured cells at 1 MOI and 5% to 10% 
at 0.1 MOI had positive assays for ]3-gal. Because of 
these results regarding cytotoxity and efficiency, we 
used the adenovirus at 10 MOI to infect the cardiac 
cells in the following studies. 
Histologieal examinations of the reeipient hearts. 
Gross histologic examination of the host hearts was 
performed every 7 days after cell transplantation up 
to 12 weeks (Fig. 3, A and B). Implanted cells 
showing blue color aligned themselves in circumfer- 
ential arrays parallel to the host myocardium. His- 
tologic analysis demonstrated that blue-stained cells 
were cardiomyocytes because of the cross striation 
in the cells (Fig. 3, C). HE staining also indicated 
that there was no myocardial fibrosis, capsule for- 
mation, nor infiltration of monocytes and leukocytes 
around the grafted cells. Immunohistochemical 
studies confirmed no inflammatory reactions (not 
shown). On the other hand, NIH 3T3 cells, which 
were incubated with the final supernatant used for 
rinsing the donor cells, had negative assays for ]3-gal 
activity. Hearts injected with the final supernatant or
14 
The Journal of Thoracic and 
Gojo et aL Cardiovascular Surgery 
January 1997 
Fig. 3. X-gal and HE staining of hearts. Histologic examination of h st hearts was carried out each week 
after implantation. A, Staining with X-gal on postoperative day 21. B, Staining with X-gal 12 weeks after 
implantation. C, Staining with HE on postoperative day 21. Blue cells aligned themselves along layers of 
host myocardium. Neither fibrous scars nor infiltrations o  neu rofils were detectable within any section. 
the plasmid DNA were not stained with X-gal. 
Moreover, blue-stained areas were not detected in 
the extracellular space of the myocardium through- 
out the experiment with this cell implantation. 
These results indicated that there were no adenovi- 
ruses within the injected solutions, and the cells 
expressing/3-gal were not host cardiomyocytes tak- 
ing up the naked plasmid DNA or /3-gal released 
from the destroyed onor cells. 
X-gal is hydrolyzed by ~-gal to generate galactose 
and soluble indoxyl molecules, which in turn are 
converted to insoluble indigo. Transmission electron 
microscopic (TEM) examination showed that donor 
and recipient cardiomyocytes were easily distin- 
guished by the presence of electron-dense indigo, 
especially in the intermyofibrillar endoplasm. The 
grafted cells possessed abundant mitochondria and 
well-organized myofibrils (Fig. 4, A). These results 
indicate that the grafted fetal cardiomyocytes differ- 
entiated into mature cardiomyocytes in the host 
heart after cell implantation. At high magnification, 
the formation of intercalated isks between graft 
and host cardiomyocytes was observed. The connec- 
tions consisted of desmosomes and gap junctions 
(Fig. 4, B). These intercalated disks between grafted 
and host cardiomyocytes were quite similar to those 
in normal adult hearts. These results demonstrate 
that the implanted cells formed functional syncytia 
with the host myocardium. 
In all cases, surface electrocardiograms were r - 
corded for 1 hour. The electrocardiographic pat- 
terns were indistinguishable b tween mice that un- 
derwent ransplantation a d control mice that did 
not (Fig. 5). No arrhythmias were detectable in the 
grafted group at anytime. As far as we tested, 
myocyte transplantation produced no adverse ef- 
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Fig. 4. TEM analysis from postoperative day 7. Cells with /3-gal possess electron-dense d posits in 
endoplasm. A, Grafted cells had abundant mitochondria, microtubles, and intercalated disks with host and 
other grafted cells. Bar indicates 2/xm. B, Desmosomes (DES.) and gap junctions (GAP.J) were clearly 
found in intercalated disks. Bar indicates 500 nm. +, Grafted cardiomyocyte; - ,  host cardiomyocyte; N, 
nucleus. 
fects on the electrical pathways of the host myocar- 
dium. 
Discussion 
The results presented here demonstrate for the 
first time that ex vivo genetically modified cardio- 
myocytes can be transplanted into the heart. We 
found that all primary fetal cardiomyocytes were 
transduced in vitro with the reporter gene without 
any damage by means of recombinant adenovirus, 
the implanted cardiac ells survived in the syngeneic 
host heart and expressed the exogenous gene in vivo 
for longer than 12 weeks, the graft formed gap 
junctions with the host ventricular myocytes or other 
grafted cells and differentiated to a mature pheno- 
type, and no adverse ffects in terms of electrocar- 
diography or histologic examinations were detect- 
able in this cellular transplantation procedure. 
We selected an adenoviral vector as the gene 
transfer vehicle because of its high transfer efficacy. 
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Fig. 5. Electrocardiograms of mice in transplanted and control groups. Electrocardiograms were recorded 
before mice in grafted group were killed for histologic and TEM examination. Recording speed was 100 
mm/min. A, Preoperative lectrocardiogram. B, Electrocardiogram at postoperative week 1. C, Electro- 
cardiogram at postoperative week 12. No significant difference in electrocardiographic pattern was found 
between grafted and control groups. In addition, no arrhythmia was recorded in grafted group at any time. 
In nonviral systems, the expression of  transduced 
genes in cardiomyocytes is only 10% to 20%, even 
under optimal conditions. 17 We previously tried 
several retroviral vectors. Because primary cultures 
of cardiac cells cannot be maintained longer than 7 
days without overgrowth of fibroblasts, the long- 
term culture and selection of gene-transduced cells 
cannot be carried out. For this reason, the efficacy of 
gene transfer was about 30%, even with Transwell 
(Costar, Cambridge, Mass.). is This study showed 
that adenovirus can infect virtually 100% of the cells 
and causes no damage to cultured cells at the MOIs  
tested here. 
To rule out the possibility that native cardiomyo- 
cytes were stained with X-gal, we examined the final 
supernatant used for rinsing the donor cardiomyo- 
cytes. Neither N IH  3T3 cells incubated with the 
solution nor hearts injected with the solution were 
stained with X-gal. These results demonstrated that 
free viruses were not contained within the injected 
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suspensions. The alternative hypothesis, that native 
cells were stained by the uptake of the reporter gene 
or ]3-gal released from the destroyed onor cells, is 
refuted by the following results. The naked plasmid 
containing /3-gal gene injections did not make the 
host cells stain with X-gal within the hearts. More- 
over, we could not find any blue-stained areas in the 
extracellular space of the hearts with grafted fetal 
cardiomyocytes. These facts strongly suggest hat 
cells with positive assays for /3-gal are not native 
cells, but donor cells. 
This study revealed a long persistence of gene 
expression. Although adenovirus-mediated gene 
transfer is considerably more efficient than other 
systems of gene transfer, many earlier studies re- 
ported that the expression of the transduced gene 
products disappeared after 4 weeks. 17q9 In neonatal 
mice, however, it has been reported that gene 
expression persisted for as long as 12 months after 
either intravenous or intramuscular (quadriceps) 
injection with recombinant adenovirus. 2°Moreover, 
cell transplantation after in vitro gene transfer with 
adenovirus has not been previously reported. In this 
study,/3-gal expression was observed for as long as 
12 weeks after adenoviral infection. Although the 
mechanism of long-term gene expression is unclear, 
we speculate that the transient expression in the 
earlier reports 17' 19 resulted from the host immune 
response to adenovirus. In the study reported by 
Stradford-Perricaudet and colleagues, 2°the animals 
injected with adenoviruses were neonates with an 
immature immune system. In our study, the host 
immune system seemed not to be stimulated against 
the adenoviruses because the donor cells were 
washed well enough to exclude adenoviruses in the 
extracellular space. This long-term expression of 
recombinant molecules can certainly be a major 
benefit for cellular transplantation. 
Gap junctions between engrafted fetal cells and 
the host myocardium were demonstrated by TEM 
examination. Gap junctions are specialized re- 
gions composed of numerous intercellular low 
resistance channels in intercalated disks. 21'22 
They facilitate the passage of electrical activity, 
which is critical to the normal functioning of the 
heart. TEM analysis revealed further that grafted 
cardiomyocytes formed abundant intercalated 
disks, including gap junctions and desmosomes, 
with recipient myocytes. This result strongly sug- 
gests that grafted cardiomyocytes may contract 
synchronously with the host heart. 
The grafted cells differentiated and adapted 
within the host heart. In TEM analysis, the en- 
grafted cells were found to possess abundant 
mitochondria nd transverse tubules. In fetal car- 
diomyocytes, these intracellular components are 
sparse. Moreover, in cellular transplantation to 
the heart, grafted cardiomyocytes must be ori- 
ented such that their contractile activity will con- 
tribute cardiac function. It has been reported that 
a mechanical tension induced orientation in a 
primary culture of adult rat cardiac myocytes. 23
Cardiomyocytes cultured under conditions of os- 
cillating tension tend to align themselves parallel 
to the direction of stretch. The force generated 
by the surrounding host myocardium ight there- 
fore influence the alignment of the grafted cells. 
The alignment of the implanted cells observed 
in this study may allow effective cooperation 
with the host myocardium. The differentiation 
and adaptation of the grafted cells are consistent 
with previous reports. 7These results suggest hat 
the grafted cells may be able to contribute to the 
host overall cardiac function. The absence of 
detectable arrhythmia is important o cardiac cell 
transplantation. Mechanical stimuli, myocardial 
infarction, and inflammation can cause lethal ar- 
rhythmias. In our experiments, no pathologic 
changes were detectable on histologic analysis, 
and the absence of arrhythmia was confirmed in 
the grafted mice. 
Our study demonstrates that in vitro gene-trans- 
ducted cardiomyocytes can be transplanted success- 
fully into the hearts of adult syngenic recipient mice, 
and grafted myocytes can form the gap junction with 
neighbor myocytes. A recent study also showed that 
fetal cardiomyocytes of transgenic mice with a/3-gal 
transgene formed intercalated disks with host cardio- 
myocytes after cell transplantation. 7 In that study, the 
/3-gal gene was used only as a marker, and the grafted 
cells were not free from fibroblasts. In our study, we 
used/3-gal as a reporter gene, but other genes could 
easily be introduced for therapeutic purposes. Because 
it is crucial in cell transplantation to obtain pure 
population of implanted cells, we attempted to purify 
the donor myocytes as rauch as possible by removing 
the fibroblasts, as described in the Methods section. 
Although we used fetal cardiomyocytes as donor cells, 
fetal cell transplantation e ge, nders an ethical quan- 
dary. Myoblast ransplantation to the heart 5' 6 and the 
skeletal muscle 24' 25 has shown promising results. It is 
unknown at present, however, whether the myoblasts 
can differentiate into mature cardiomyocytes within 
the heart and incorporate with the host myocardium. 
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In the future, genetically engineered cardiac ell trans- 
plantation may become arealistic therapeutic modality 
for acute or chronic heart failure with significant 
myocyte loss. 
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